Document Detail


Perfusion-weighted MRI as a marker of response to treatment in acute and subacute stroke.
MedLine Citation:
PMID:  14673553     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
We carried out baseline and short-term follow-up MRI, including perfusion-weighted imaging (PWI) and tests of neurologic and cognitive function on 15 consecutive patients with large-vessel ischemic stroke who showed a persistent large perfusion-diffusion mismatch at enrollment up to seven days after the onset of symptoms. Of these, ten underwent induced blood pressure elevation with phenylephrine and oral medications (in eight) or intravenous fluids (in two) with the goal of improving perfusion; five had no such treatment. Significant functional improvement was defined by a reduction of 3 or more points on the NIH stroke scale (NIHSS). Significant improvement in perfusion was defined by a reduction in the volume of hypoperfused brain by 30 cc on PWI using time-to-peak (TTP) maps, without enlargement of the infarct. There was a strong, statistically significant association between improved function and improved perfusion: six (75%) of eight patients who improved in function, but none of the seven who did not, showed a reduction in volume of hypoperfused brain. All six patients who met the perfusion goal, and only two (22%) of nine who did not showed significant functional improvement (Fisher's exact: P < 0.01). There were no differences between patients who improved functionally and those who did not with respect to age, initial volume of abnormality on DWI or PWI, initial NIHSS, or changes on DWI. These findings indicate that reduction in volume of hypoperfused brain on PWI is a marker of response to treatment to improve perfusion even in subacute stroke and that partial reperfusion of regions of salvageable but dysfunctional tissue is a mechanism of improved function associated with induced blood pressure elevation.
Authors:
A E Hillis; R J Wityk; N J Beauchamp; J A Ulatowski; M A Jacobs; P B Barker
Related Documents :
23921903 - Regulation of optic nerve head blood flow during combined changes in intraocular pressu...
9747433 - Effects of vasodilators and perfusion pressure on coronary flow and simultaneous releas...
21095973 - Validity of a new method to estimate mean arterial pressure at brachial level.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.     Date:  2003-12-12
Journal Detail:
Title:  Neuroradiology     Volume:  46     ISSN:  0028-3940     ISO Abbreviation:  Neuroradiology     Publication Date:  2004 Jan 
Date Detail:
Created Date:  2004-02-03     Completed Date:  2004-10-19     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  1302751     Medline TA:  Neuroradiology     Country:  Germany    
Other Details:
Languages:  eng     Pagination:  31-9     Citation Subset:  IM    
Affiliation:
Department of Cognitive Science, Johns Hopkins Hospital, Baltimore, MD 21287, USA. argye@JHMI.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Aged, 80 and over
Brain / blood supply
Brain Ischemia / complications*
Cardiotonic Agents / therapeutic use
Cognition Disorders / etiology*
Endpoint Determination
Female
Fluid Therapy
Follow-Up Studies
Humans
Magnetic Resonance Angiography*
Male
Middle Aged
Phenylephrine / therapeutic use
Prognosis
Prospective Studies
Sensitivity and Specificity
Severity of Illness Index
Stroke / diagnosis*,  therapy*
Treatment Outcome
Grant Support
ID/Acronym/Agency:
K23 DC00174-01/DC/NIDCD NIH HHS
Chemical
Reg. No./Substance:
0/Cardiotonic Agents; 59-42-7/Phenylephrine

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Revascularization of the testis using a vascular induction technique: a potential approach for stage...
Next Document:  Comparison of conventional and diffusion-weighted MRI and proton MR spectroscopy in patients with mi...